Dmitry Balyasny’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$344K Buy
+207,277
New +$330K ﹤0.01% 2703

Other funds holding CRDL

Dmitry Balyasny's CRDL Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 207,277 shares worth $344K. The stake represents ﹤0.01% of the portfolio and ranks #2703 among its holdings.

59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Dmitry Balyasny held 207,277 shares of Cardiol Therapeutics worth $344K as of Q3 2026.
  • Cardiol Therapeutics was a new Dmitry Balyasny position in Q3 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2703 holding.
  • 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.